HBOT is not a primary treatment for most digestive disorders, but HBOT in Edmonton may be considered as a complementary therapy in appropriately selected patients, particularly when tissue healing or other specific clinical indications are relevant
Metsera reports positive phase 2b results for first- and best-in-class ultra-long acting GLP-1 RA candidate MET-097i, enabling rapid transition into phase 3
A 2024 case series in Journal of Clinical Endocrinology reported that patients receiving combination therapy showed 18% greater fat mass reduction compared to GLP-1 monotherapy, with improved energy scores on validated fatigue assessments (Morrison et al., 2024)
Intense Hydration & Moisture Provides deep nourishment, making the skin soft, smooth, and radiant
Protocols, doses, and reactions reported below come from published clinical trials and self-reported community sources
The procedure typically takes about 30-60 minutes